Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Platelet aggregation inhibitors in development at Meiji Seika

July 6, 1998

FDA advisory committee to review Pletal NDA next week

July 3, 1998

Zeria discloses new thromboxane antagonists for thrombosis

July 3, 1998

HMR introduces Refludan in U.S.

July 2, 1998

Factor Xa inhibitors developed by Boehringer Mannheim researchers

June 30, 1998

RPR acquires worldwide rights to Novartis anticoagulant

June 29, 1998

Schering-Plough initiates phase I with oral antithrombotic

June 25, 1998

BioChem Pharma describes lactams for thrombotic disorders

June 23, 1998

Eisai launches monteplase in first market

June 16, 1998

Bayer seeks FDA approval for improved second-generation hemophilia A product

June 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...